GastroAGI Logo
OverviewBlogsAbout
Trending TopicsConference
Topics/Endoscopy/Prophylactic Rectal ESD Defect Closure and Post-ESD Outcomes

Prophylactic Rectal ESD Defect Closure and Post-ESD Outcomes

Clinical knowledge base curated and reviewed by GastroAGI TeamLast updated January 1, 2025

Quick Answer

The study explored the impact of prophylactic closure of rectal ESD (endoscopic submucosal dissection) defects on post-ESD outcomes, focusing on delayed adverse events (DAEs) and post-procedure hospitalization. Here are the key findings: ### Study Details: - **Objective**: To determine whether closing rectal ESD defects prophylactically improves short-term clinical outcomes, particularly reducing delayed bleeding, perforation, and hospitalization.


The study explored the impact of prophylactic closure of rectal ESD (endoscopic submucosal dissection) defects on post-ESD outcomes, focusing on delayed adverse events (DAEs) and post-procedure hospitalization. Here are the key findings:

### Study Details:

  • **Objective**: To determine whether closing rectal ESD defects prophylactically improves short-term clinical outcomes, particularly reducing delayed bleeding, perforation, and hospitalization.
  • **Population**: 385 patients who underwent rectal ESD between 2016 and 2023 across 12 centers in North America and Europe. Patients with intraprocedural perforation were excluded.
  • **Intervention**: Defect closure was achieved in 166 patients (43%) using techniques like endoscopic suturing, clips, or other closure devices.
  • **Outcome Measures**: Delayed adverse events (DAEs) — defined as bleeding or perforation within two weeks — and post-procedure hospitalization rates were analyzed.

### Key Findings:

1. **Delayed Adverse Events (DAEs)**:

  • Overall, DAEs occurred in **5.5%** of patients.
  • Risk factors for DAEs included chronic anticoagulant use, NICE 3 lesions (high-risk features), and incomplete resections.
  • Prophylactic defect closure did not significantly reduce the overall rate of DAEs compared to leaving defects open.
  • **Delayed perforations** were observed exclusively in the open-defect group, while no perforations occurred in patients with closed defects.

2. **Hospitalization and Recovery**:

  • Patients with defect closure had significantly lower rates of overnight hospital admission or observation following ESD.
  • This suggests that defect closure may improve post-procedure recovery and reduce healthcare resource utilization.

3. **High-Risk Subgroups**:

  • In patients with higher risk factors (e.g., anticoagulant use or challenging lesions), defect closure showed a numerical reduction in DAEs, though the difference was not statistically significant.

### Clinical Implications:

  • **Routine Closure**: The study indicates that prophylactic closure may not be necessary for all rectal ESD cases.
  • **Selective Closure**: Closure is recommended for high-risk patients (e.g., those on anticoagulants or with high-risk lesions) to reduce complications like delayed perforation and hospitalization.

### Conclusion:

Prophylactic closure of rectal ESD defects has nuanced benefits. While it may not universally reduce delayed adverse events, it prevents delayed perforation and improves post-procedure recovery, particularly in high-risk patients. The findings suggest a tailored approach, focusing on selective closure for patients with elevated risk profiles to optimize outcomes and resource utilization.

Related Q&A

EndoBarrier Improves Diabetes and Weight Loss: Ann Surg | July 2026

Introduction: Endoscopic metabolic therapies have emerged as less invasive alternatives to bariatric surgery for patients with obesity and poorly controlled type 2 diabetes mellitus (T2DM). The EndoBarrier duodenal-jejunal bypass liner (DJBL) is an endoscopically placed...

Immediate Endoscopic Necrosectomy in Necrotizing Pancreatitis: Gastroenterology | July 2026

Introduction: Endoscopic ultrasound (EUS)-guided transmural drainage is the standard minimally invasive treatment for symptomatic necrotizing pancreatitis. However, the optimal timing of direct endoscopic necrosectomy (DEN) following drainage remains uncertain. While the conventional step-up approach reserves...

Endoscopy After Bevacizumab Appears Safe: GIE | July 2026

Introduction: Bevacizumab is widely used in metastatic colorectal cancer (mCRC) because of its survival benefits but is associated with impaired wound healing, gastrointestinal perforation, and bleeding. These concerns often lead clinicians to delay endoscopic procedures...

Colorectal ESD Perforation: Endoscopy | July 2026

Introduction: Endoscopic submucosal dissection (ESD) enables en bloc resection of large colorectal neoplasms with excellent oncological outcomes. However, concerns about perforation have limited its widespread adoption. This large prospective multicenter study evaluated the incidence, risk...

Duodenal Mucosal Resurfacing REMAIN-1 Study: DDW | 2026

Introduction: Obesity has become one of the greatest global health challenges. New incretin-based therapies—including semaglutide, tirzepatide, resmetirom, and SGLT2 inhibitors such as empagliflozin—have transformed the treatment of obesity, diabetes, and MASLD. However, many patients discontinue...

EUS-FNAB for Solid Pancreatic Lesions: GIE | July 2026

Introduction: Endoscopic ultrasound-guided fine-needle biopsy (EUS-FNB) is the standard technique for diagnosing solid pancreatic lesions. Traditionally, biopsy specimens are processed for cytology, often requiring on-site cytopathology support. This multicenter prospective study evaluated whether directly placing...

GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersSoonFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer